Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Change in Acquisitions & Divestments (2016 - 2025)

Ultragenyx Pharmaceutical has reported Change in Acquisitions & Divestments over the past 10 years, most recently at -$143000.0 for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 3.38% to -$143000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5000.0 through Sep 2025, down 100.08% year-over-year, with the annual reading at $3.0 million for FY2024, 94.12% down from the prior year.
  • Change in Acquisitions & Divestments was -$143000.0 for Q4 2025 at Ultragenyx Pharmaceutical, up from -$136.8 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $513.4 million in Q3 2021 and troughed at -$491.1 million in Q4 2021.
  • The 5-year median for Change in Acquisitions & Divestments is $2.8 million (2024), against an average of $12.2 million.
  • Year-over-year, Change in Acquisitions & Divestments surged 11138.83% in 2023 and then plummeted 77364.97% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at -$491.1 million in 2021, then surged by 34.1% to -$323.7 million in 2022, then surged by 101.08% to $3.5 million in 2023, then tumbled by 104.25% to -$148000.0 in 2024, then rose by 3.38% to -$143000.0 in 2025.
  • Per Business Quant, the three most recent readings for RARE's Change in Acquisitions & Divestments are -$143000.0 (Q4 2025), -$136.8 million (Q2 2025), and $136.9 million (Q1 2025).